DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Wednesday reported a first-quarter loss of $721.8 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of $2.98. Losses, adjusted for research and development costs and non-recurring costs, were 3 cents per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 6 cents per share.
The drugmaker posted revenue of $156.4 million in the period.
BioCryst expects full-year revenue in the range of $635 million to $660 million.
BioCryst shares have climbed 16% since the beginning of the year. The stock has decreased 18% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
